Genzyme, who are responsible for taking Ataluren through outside of N America are holding a conference call on Monday 13 September for representatives of patient organizations. If you have any specific questions that you would like asked, please email me at mark@actionduchenne.org as soon as possible
Thanks

Mark

Views: 202

Reply to This

Replies to This Discussion

Yes, you are sure there was inverted U-curve. But I did not really understand if there is speaking about ataluren approval or IND for people from IIb phase trial.
Thank you very much.

Ofir Arad said:
Low-dose PTC124 = 10 mg/kg in the morning, 10 mg/kg at midday, and 20 mg/kg in the evening

Reply to Discussion

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service